FDA given new powers over data reporting to national clinical trials registry

@article{Roehr2012FDAGN,
  title={FDA given new powers over data reporting to national clinical trials registry},
  author={B. Roehr},
  journal={BMJ : British Medical Journal},
  year={2012},
  volume={345}
}
  • B. Roehr
  • Published 2012
  • Medicine
  • BMJ : British Medical Journal
  • The US Food and Drug Administration (FDA) has been given the authority to monitor and enforce the reporting of required data to the national clinical trials registry (ClinicalTrials.gov). Authority for the registry previously rested with the Secretary of Health but was transferred to the FDA on 26 September.1 The move is seen as a streamlining or rationalization of administrative responsibilities and will probably result in enhanced accountability. The National Institute for Health’s (NIH… CONTINUE READING
    2 Citations
    Health minister agrees to meet academics to discuss access to clinical trial data
    • 5
    Public availability of results of trials assessing cancer drugs in the United States.
    • 39

    References